NPPB and pulmonary arterial hypertension: In contrast, sRAGE outperformed NTproBNP in the PAH FC I (mild PAH) vs. healthy control comparison as the area under the ROC curve was 0.701 for sRAGE, compared to 0.677 for NTproBNP (Figure 3D).